Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma
Open Access
- 18 March 2019
- journal article
- conference paper
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 106 (5) , 519-522
Abstract
This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection.Keywords
This publication has 14 references indexed in Scilit:
- Feasibility of magnetic marker localisation for non-palpable breast cancerThe Breast, 2017
- Starting a Radioactive Seed Localization ProgramAnnals of Surgical Oncology, 2015
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2015
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated MelanomaNew England Journal of Medicine, 2015
- Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer PatientsAnnals of Surgery, 2015
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Neoadjuvant chemotherapy for operable breast cancerBritish Journal of Surgery, 2007
- Radioactive seed localization for excision of non-palpable in-transit metastatic melanomaRadiology Case Reports, 2006